# Isoniazid

## Isoniazide 100mg

| TAH Drug Code      | [OINH1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OINH1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of susceptible active tuberculosis (eg, Mycobacterium tuberculosis) infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | (仿單) Adult: 50-200 mg/day in 3-5 divided doses after meals. (UpToDate) DOT = directly observed therapy. Adult: Once-daily therapy: 5 mg/kg/dose (usual dose: 300 mg) once daily; Three-times-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered 3 times weekly; Twice-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered twice weekly; Once-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered once weekly.Pediatrc: Once daily therapy: children < 15 years, weighing < or = 40 kg: 10-15 mg/kg/dose once daily (maximum 300 mg/dose); children < 15 years weighing > 40 kg or children > or = 15 years: 5 mg/kg/dose once daily; typical dose: 300 mg/dose. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | ‧Acute liver disease. ‧History of severe adverse reactions to isoniazid such as drug fever, chills, or arthritis. ‧History of isoniazid associated hepatic injury or drug induced liver injury. ‧Severe hypersensitivity to isoniazid.                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Common ‧Hepatic: Increased liver enzymes (10% to 20% ) ‧Neurologic: Neuropathy, Neurotoxicity Serious ‧Dermatologic: Rash ‧Hematologic: Agranulocytosis, Anemia, Thrombocytopenia ‧Hepatic: Hepatitis (Severe), Hepatotoxicity, Injury of liver ‧Immunologic: Systemic lupus erythematosus ‧Musculoskeletal: Rhabdomyolysis ‧Neurologic: Seizure                                                                                                                                                                                                                                                                                                                                           |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/isoniazid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## ISONIAZID 300mg (Government)

| TAH Drug Code      | [OINH3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OINH3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of susceptible active tuberculosis (eg, Mycobacterium tuberculosis) infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | (UpToDate) DOT = directly observed therapy. Adult: Once-daily therapy: 5 mg/kg/dose (usual dose: 300 mg) once daily; Three-times-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered 3 times weekly; Twice-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered twice weekly; Once-weekly DOT: 15 mg/kg/dose (usual dose: 900 mg) administered once weekly.Pediatrc: Once daily therapy: children < 15 years, weighing < or = 40 kg: 10-15 mg/kg/dose once daily (maximum 300 mg/dose); children < 15 years weighing > 40 kg or children > or = 15 years: 5 mg/kg/dose once daily; typical dose: 300 mg/dose. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | ‧Acute liver disease. ‧History of severe adverse reactions to isoniazid such as drug fever, chills, or arthritis. ‧History of isoniazid associated hepatic injury or drug induced liver injury. ‧Severe hypersensitivity to isoniazid.                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common ‧Hepatic: Increased liver enzymes (10% to 20% ) ‧Neurologic: Neuropathy, Neurotoxicity Serious ‧Dermatologic: Rash ‧Hematologic: Agranulocytosis, Anemia, Thrombocytopenia ‧Hepatic: Hepatitis (Severe), Hepatotoxicity, Injury of liver ‧Immunologic: Systemic lupus erythematosus ‧Musculoskeletal: Rhabdomyolysis ‧Neurologic: Seizure                                                                                                                                                                                                                                                                             |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/isoniazid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

